help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orcel, P.
Right arrow Articles by Nishimoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orcel, P.
Right arrow Articles by Nishimoto, I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Molecular Endocrinology 14 (1):170
Copyright © 2000 by The Endocrine Society

Multiple Domains Interacting with Gs in the Porcine Calcitonin Receptor

Philippe Orcel1, Hirohisa Tajima1, Yoshitake Murayama, Toshiro Fujita, Stephen M. Krane, Etsuro Ogata, Steven R. Goldring and Ikuo Nishimoto

Department of Medicine (P.O., S.M.K., S.R.G., I.N.) Harvard Medical School Cardiovascular Research Center and Arthritis Research Massachusetts General Hospital-East Charlestown, Massachusetts 02129
INSERM U349 (P.O.) Centre Viggo Petersen Hopital Lariboisière 75010 Paris, France
Department of Pharmacology and Neurosciences (H.T., I.N.) KEIO University School of Medicine Tokyo 160, Japan
Department of Medicine (Y.M., T. F.) University of Tokyo School of Medicine Mejirodai, Bunkyo-ku Tokyo 113, Japan
Cancer Research Center (E.O.) Toshima-ku, Tokyo 170, Japan
Department of Medicine (S.R.G.) Beth Israel Deaconess Medical Center and New England Baptist Bone and Joint Institute Harvard Institutes of Medicine Boston, Massachusetts 02215

The molecular basis for Gs activation by the calcitonin (CT) receptor was investigated. Based upon the analysis of conserved regions in G protein-coupled receptors, two nonoverlapping regions in the heptahelical porcine CT receptor (CTR) were selected as candidate Gs-interacting domains: the third intracellular loop residues 327–344 (KLKESQEAESHMYLKAVR, P3 region) and the C-tail residues 404–418 (KRQWNQYQAQRWAGR, P4 region). To assess their Gs-interacting function, we expressed these sequences in hybrid insulin-like growth factor II receptors in which the receptor native Gi-interacting domain was converted to CTR sequences. In COS cells transfected with either P3- or P4-substituted hybrid receptor, membrane adenylyl cyclase activity significantly increased. The up-regulated activity of cAMP was confirmed by measuring the transcriptional activity of the cAMP response element in cells expressing either hybrid receptor. A mutant CTR lacking the P4 region maintained positive cAMP response but with an attenuated maximal capacity to produce cAMP. In contrast, we could not assess the function of the P3 region using a conventional deletion method, as CT bound poorly to cells transfected with either of the two P3-deficient CTRs (one lacking the P3 region and the other lacking P3 but having the P3 sequence in reverse orientation). These data suggest that the third intracellular loop and the C-tail in CTR have domain-specific roles in Gs activation and that the hybrid receptor approach used here, combined with a conventional mutagenesis approach, is useful for intact cell analysis and functional dissection of G protein-coupled receptors.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
E. Kostenis, L. Martini, J. Ellis, M. Waldhoer, A. Heydorn, M. M. Rosenkilde, P. K. Norregaard, R. Jorgensen, J. L. Whistler, and G. Milligan
A Highly Conserved Glycine within Linker I and the Extreme C Terminus of G Protein {alpha} Subunits Interact Cooperatively in Switching G Protein-Coupled Receptor-to-Effector Specificity
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 78 - 87.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society